Syngene Q3 profit jumps 31% to Rs 59 cr.
Business Standard-21/01/2016. Syngene reported a 31% jump in third quarter profits to Rs 59 crore and 23% growth in revenues to Rs 281 crore on improved business from its global clients to help build new drug discovery.
India has 'natural potential to grow' in CRO space, says Syngene CEO
Outsourcing Pharma-14/01/2016. An exclusive interview with Peter Bains- CEO ,Syngene International Ltd -
Syngene appoints Jonathan Hunt as CEO-designate.
Business Today-05/01/2016. Syngene appoints Jonathan Hunt as CEO-designate. Mr Hunt to take charge post retirement of current CEO Peter Bains. Mr Bains will continue as a member of the Syngene Board.